BioPharmX Corp (29)
Browse by Contract Category
Contracts
-
Form of Waiver Agreement, dated as of November 19, 2020, by and between Timber Pharmaceuticals, Inc. and the Holders
(Filed With SEC on November 20, 2020)
-
Form of Indemnification Agreement
(Filed With SEC on May 22, 2020)
-
Offer Letter, dated March 31, 2020, between Joseph Lucchese and Timber Sub
(Filed With SEC on May 22, 2020)
-
Amendment No. 2 to Agreement and Plan of Merger, dated April 27, 2020, among BioPharmX, Timber and Merger Sub
(Filed With SEC on April 27, 2020)
-
License Agreement, dated July 5, 2019, by and between AFT and Timber
(Filed With SEC on February 20, 2020)
-
Consulting Services Agreement, dated January 8, 2020, by and between Timber Pharmaceuticals, LLC and AT Consulting LLC
(Filed With SEC on February 20, 2020)
-
Sublease Agreement between BioPharmX, Inc. and Full Cycle Bioplastics Inc., dated February 14, 2020
(Filed With SEC on February 18, 2020)
-
Amended and Restated Registration Rights Agreement, dated July 17, 2020, by and between Timber Pharmaceuticals, Inc. and certain buyers named therein
(Filed With SEC on August 18, 2020)
-
Form of B Warrant
(Filed With SEC on June 3, 2020)
-
Form of A Warrant
(Filed With SEC on June 3, 2020)
-
Offer Letter, dated March 31, 2020, between Michael Derby and Timber Sub
(Filed With SEC on May 22, 2020)
-
Offer Letter, dated March 31, 2020, between Zachary Rome and Timber Sub
(Filed With SEC on May 22, 2020)
-
Form of Amendment No. 1 to Securities Purchase Agreement, dated April 27, 2020, by and among Timber, BioPharmX and certain investors parties thereto
(Filed With SEC on April 27, 2020)
-
Description of Capital Stock
(Filed With SEC on March 23, 2020)
-
Management Services Agreement, dated January 1, 2020, by and between TardiMed and Timber
(Filed With SEC on February 20, 2020)
-
Asset Acquisition Agreement, dated June 26, 2019, by and among Timber, Patagonia, Jonathan Rome and Zachary Rome
(Filed With SEC on February 20, 2020)
-
Offer Letter, dated June 20, 2019, between John Koconis and Timber
(Filed With SEC on February 20, 2020)
-
Asset Acquisition Agreement, dated February 28, 2019, by and among Timber, Patagonia, Johnathan Rome and Zachary Rome
(Filed With SEC on February 20, 2020)
-
Agreement and Plan of Merger and Reorganization, dated January 28, 2020, among BioPharmX, Timber and Merger Sub
(Filed With SEC on January 29, 2020)
-
Form of Exchange Agreement, dated January 28, 2020, between BioPharmX and the Holders
(Filed With SEC on January 29, 2020)
-
Form of Stockholder Support Agreement
(Filed With SEC on January 29, 2020)
-
Note, dated January 28, 2020, made by BioPharmX in favor of Timber
(Filed With SEC on January 29, 2020)
-
Bridge Loan Credit Agreement, dated January 28, 2020, between BioPharmX and Timber
(Filed With SEC on January 29, 2020)
-
Bridge Warrant To Purchase Common Stock, dated January 28, 2020, made by BioPharmX in favor of Timber
(Filed With SEC on January 29, 2020)
-
Consulting Agreement between Kin Chan and BioPharmX, Inc., as amended
(Filed With SEC on September 9, 2019)
-
Offer Letter between Steven Bosacki and the Company, effective as of July 16, 2019
(Filed With SEC on July 17, 2019)
-
Capital on DemandTM Sales Agreement, dated May 16, 2019, by and between BioPharmX Corporation and JonesTrading Institutional Services LLC
(Filed With SEC on May 16, 2019)
-
Placement Agency Agreement
(Filed With SEC on March 21, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on March 21, 2019)
